Plasma GPX activity negatively correlates with non-EoE atopic disease in pediatric subjects only

An exploratory study investigated whether plasma glutathione peroxidase (GPX) activity could serve as a non-invasive biomarker for atopic diseases, including eosinophilic esophagitis (EoE), in pediatric and adult subjects. The specific intervention or exposure, comparator, sample size, setting, and follow-up duration were not reported. The primary outcome was the correlation between plasma GPX activity levels and EoE disease activity, while secondary outcomes included correlation with other atopic diseases.

The main results showed plasma GPX activity levels did not correlate with EoE. However, in pediatric subjects, plasma GPX activity levels were negatively correlated with non-EoE atopic disease. This correlation was not observed in adult subjects. No effect sizes, absolute numbers, or statistical measures (p-values or confidence intervals) were reported for these correlations. The authors note these findings represent correlation, not causation.

Safety and tolerability data were not reported. Key limitations include the exploratory nature of the study and the explicit need for future research to determine clinical utility and underlying biological mechanisms. Given the preliminary design and lack of reported statistical details, these findings should be interpreted cautiously and do not yet support clinical application. The study's funding and conflicts of interest were not reported.